Early menarche and worse cardiovascular health: an emerging risk factor?
Published in Menopause (New York, N.Y.)
To the Editor.
Published in Menopause (New York, N.Y.)
Vaginal elasticity is significantly decreased in vaginal atrophy: a strain elastography study.
Published in Menopause (New York, N.Y.)
Strain elastography is a novel method to assess the elasticity of tissues. We aimed to evaluate the value of vaginal strain elastography in women with vulvovaginal atrophy (VVA). Women with or without VVA were enrolled in this prospective study. Participants underwent vaginal cytology and vaginal wall elastography. Vaginal Health Index (VHI) was ca...
Fezolinetant findings can fuel future instrumentation inquiries.
Published in Menopause (New York, N.Y.)
Medroxyprogesterone opposes estradiol-induced renal damage in midlife ovariectomized Long Evans rats.
Published in Menopause (New York, N.Y.)
Our laboratory previously published that long-term administration of estradiol (E2) was detrimental to the kidneys of midlife ovariectomized Long Evans rats, contrasting clinical studies in showing that menopausal hormone therapy is associated with decreased albuminuria. However, it is unknown whether this renal benefit was due to estrogen and/or t...
In Reply.
Published in Menopause (New York, N.Y.)
Efficacy of progestin-only treatment for the management of menopausal symptoms: a systematic review.
Published in Menopause (New York, N.Y.)
Menopause is associated with bothersome symptoms for many women, including mood changes, hot flushes, sleep problems, and fatigue. Progesterone is commonly prescribed in combination with estrogen therapy. Although monotherapy with progestins has been used as treatment of menopausal symptoms in women with contraindications to estrogens, the optimal ...
A selective serotonin receptor agonist for weight loss and management of menopausal vasomotor symptoms in overweight mid...
Published in Menopause (New York, N.Y.)
Weight gain and vasomotor symptoms (VMS) are common complaints in midlife women going through the menopause transition. A selective serotonin 2C (5-HT2C) receptor agonist, lorcaserin, which was previously approved by the Food and Drug Administration for weight loss, has unreported observational evidence suggesting improvement in VMS with its use. T...
The severity of vasomotor symptoms and number of menopausal symptoms in postmenopausal women and select clinical health ...
...Published in Menopause (New York, N.Y.)
This study evaluated whether vasomotor symptom (VMS) severity and number of moderate/severe menopausal symptoms (nMS) were associated with health outcomes, and whether calcium and vitamin D (CaD) modified the risks. The Women's Health Initiative CaD study was a double blind, randomized, placebo-controlled trial, which tested 400 IU of 25-hydroxyvit...
Expression of androgen receptors in the structures of vulvovaginal tissue.
Published in Menopause (New York, N.Y.)
Little is known about the role of androgens in the female genital tract, specifically in the vulvovaginal area. The abundance of androgen receptors in this area could help us to explain their role. The main objective of the present article is to review current data on androgen receptors in the different structures of vulvovaginal tissues. A review ...
